Postoperative Spasm of Mammary-Coronary Grafts and Possibilities of Its Correction by Dihydropyridine Calcium Antagonists Nifedipine and Amlodipine

Kardiologiya

Volumn 42, Issue 10, 2002, Pages 9-14

  Teplyakov, A T ^a   Vechersky, Yu Yu ^a   Mamchur, S E ^a   Dzhavadova, G K ^a   Nemik, B M ^a  

^a NONE

Author keywords

Amlodipine; Calcium antagonists; Coronary artery bypass grafting; Internal mammary artery; Nifedipine

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; NIFEDIPINE; VASODILATOR AGENT;

ARTICLE; BLOOD FLOW VELOCITY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIASTOLE; HEART MUSCLE REVASCULARIZATION; HUMAN; MALE; MIDDLE AGED; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; SYSTOLE; TIME; TREATMENT OUTCOME;

AMLODIPINE; BLOOD FLOW VELOCITY; CALCIUM CHANNEL BLOCKERS; CORONARY CIRCULATION; DIASTOLE; HUMANS; INTERNAL MAMMARY-CORONARY ARTERY ANASTOMOSIS; MALE; MIDDLE AGED; NIFEDIPINE; POSTOPERATIVE COMPLICATIONS; SYSTOLE; TIME FACTORS; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 0347934592     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Cooper G.J., Locke T.J. Distension reduces the vasoreactivity of the internal mammary artery. Eur J Cardio-Thoracic Surg 1996; 10: 26-31.
2. He G.W., Acuff T.E., Ryan W.H. et al. Inhibitory effects of calcium antagonists on alpha-adrenoceptor-mediated contraction in the human internal mammary artery. Br J Clin Pharmacol 1994; 37: 173-179.
3. Huraux C., Makita T., Montes F. et al. A comparative evaluation of the effects of multiple vasodilators on human internal mammary artery. Anesthesiology 1998; 88: 1654-1659.
4. Schyvens C.G., Owe-Young R.A., Spratt P.M. et al. Papaverive abolishes endothelium-dependent dilatation of human internal mammary arteries in vitro. Clin Exper Pharmacol Physiol 1997; 24: 223-228.
5. Huraux C., Makita T., Szlam F. et al. The vasodilator effects of clevidipine on human inlernal mammary artery. Anesthesia and Analgesia 1997; 85: 1000-1004.
6. Liu J.J., Johnston C.I., Buxton B.F. Synergistic effect of nisoldipine and nitroglycerin on human internal mammary artery. J Pharmacol Exper Ther 1994; 268: 434-440.
7. Shapira O.M., Xu A., Vita J.A. et al. Nitroglycerin is superior to diltiazem as a coronary bypass conduit vasodilator. J Thoracic Cardiovasc Surg 1999; 117: 906-911.
8. He G.W., Yang C.Q. Radial artery has higher receptor-mediated contractility but similar endothelial function compared with mammary artery. Ann Thoracic Surg 1997; 63: 1346-1352.
9. Yildiz O., Cicek S., Ay I. et al. Hypertension increases the contractions to sumatriptan in the human internal mammary artery. Ann Thoracic Surg 1996; 62: 1392-1396.
10. Caputo M., Nicolini F., Franciozi G., Gallotti R. Coronary artery spasm after coronary artery bypass grafting. Eur J Cardio-Thoracic Surg 1999; 15: 545-548.
11. Palerme L.P., De Varennes B., Steinmetz, O.K. Intraoperative duplex study of internal thoracic artery spasm during coronary bypass. J Cardiac Surg 1997; 12: 403-405.
12. Dregelid E., Heldal K., Resch F. et al. Dilation of the internal mammary artery by external and intraluminal papaverine application. J Thoracic Cardiovasc Surg 1995; 110: 697-703.
13. Gurevitch J., Miller H.I., Shapira I. et al. High-dose isosorbide dinitrate for myocardial revascularization with composite arterial grafts. Ann Thoracic Surg 1997; 63: 382-387.
14. Nili M., Stamler A., Sulkes J., Vidne B.A. Preparation of the internal thoracic artery by vasodilator drugs: is it really necessary? A randomized double-blind placebo-controlled clinical study. Eur J Cardio-Thoracic Surg 1999; 16: 560-563.
15. Sasson L., Cohen A.J., Hauptman E., Schachner A. Effect of topical vasodilators on internal mammary arteries. Ann Thoracic Surg 1995; 59: 494-496.
16. He G.W., Buxton B.F., Rosenfeldt F.L. et al. Pharmacologic dilatation of the internal mammary artery during coronary bypass grafting. J Thoracic Cardiovasc Surg 1994; 107: 1440-1444.
17. Toyo-Oka T., Nayler W.G. Third generation calcium entry blockers. Blood pressure 1996; Suppl: 206-208.
18. Neaton J.D., Grimm R.H., Jr., Prineas R.J. et al. for the Treatment of Mild Hypertension Study Research Group. Treatment of Mild Hypertension Study: final results. JAMA 1993; 270: 713-724.
19. Hoffman B.B., Lejkowitz R.J. Adrenergic receptor antagonists. In: A. Goodman Gilman, T.W. Rail, A.S. Nies, P. Taylor. The pharmacological basis in therapeutics. English edition. Pergamon Press 1990; 221-243.
20. Chanine R.A., Feldman R.L., Giles T.D. Randomized placebo-controlled trial of amlodipine in vasospastic angina. J Am Coll Cardiol 1993; 21: 1365-1370.
21. Grandjean J.G., Voors A.A., Boonstra P.W. et al. Exclusive use of arterial grafts in coronary artery bypass operations for three-vessel disease: use of both thoracic arteries and the gastroepiploic artery in 256 consecutive patients. J Thoracic Cardiovasc Surg 1996; 112: 935-942.
22. Bergsma T.M., Grandjean J.G., Voors A.A. et al. Low recurrence of angina pectoris after coronary artery bypass graft surgery with bilateral internal thoracic and right gastroepi ploic arteries.Circulation 1998; 97: 2402-2405.
23. Johnson A.M., Kron I.L., Watson D.D. et al. Evaluation ofpostoperative flow reserve in internal mammary artery bypass grafts. J Thoracic Cardiovasc Surg 1986; 92: 822-826.
24. Kawasuji M., Tedoriya T., Takemura H. et al. Flow capacities of arterial grafts for coronary artery bypass grafting. Ann Thoracic Surg 1993; 56: 957-962.